Alpelisib
Product Specifications
Background
Alpelisib is a potent and selective (IC50s = 7.4 nM PI3Kα; 2.2 µM PI3Kß; 1.2 µM PI3KIδ; 50-fold selectivity against 442 tested kinases) PI3Kα inhibitor.1 Approved for use in the treatment of HR (+), HER2 (-), PIK3CA-mutated breast cancer. Alpelisib has been used in combination with various chemotherapeutics to treat ovarian2, colorectal3, kidney4, bladder5, and head and neck6 cancers.
Conjugation
Unconjugated
Buffer
White solid
Storage Conditions
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6195980-01 0.1 mL
HLA-A (Major Histocompatibility Complex, Class I, A, HLAA) (MaxLight 405)
Ask
View Details 
MBS6195980-02 5x 0.1 mL
HLA-A (Major Histocompatibility Complex, Class I, A, HLAA) (MaxLight 405)
Ask
View Details